A detailed history of Korea Investment Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Korea Investment Corp holds 1,989,065 shares of BMY stock, worth $115 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,989,065
Previous 1,247,893 59.39%
Holding current value
$115 Million
Previous $51.8 Million 98.62%
% of portfolio
0.25%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $29.4 Million - $38.4 Million
741,172 Added 59.39%
1,989,065 $103 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $15.7 Million - $20.7 Million
-390,588 Reduced 23.84%
1,247,893 $51.8 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $1.47 Million - $1.67 Million
-30,638 Reduced 1.84%
1,638,481 $88.9 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $2.29 Million - $2.74 Million
47,326 Added 2.92%
1,669,119 $85.6 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $613,518 - $686,008
-10,598 Reduced 0.65%
1,621,793 $94.1 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $5.73 Million - $6.37 Million
-89,992 Reduced 5.22%
1,632,391 $104 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $6.33 Million - $7.18 Million
96,274 Added 5.92%
1,722,383 $119 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $29.1 Million - $34.4 Million
-424,252 Reduced 20.69%
1,626,109 $117 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $11,013 - $6.51 Million
-84,718 Reduced 3.97%
2,050,361 $146 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $22 Million - $24.2 Million
302,477 Added 16.51%
2,135,079 $164 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $23 Million - $27.5 Million
373,317 Added 25.58%
1,832,602 $134 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $6.23 Million - $7.26 Million
116,201 Added 8.65%
1,459,285 $91 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $13.4 Million - $15.7 Million
-227,030 Reduced 14.46%
1,343,084 $79.5 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $7.66 Million - $8.34 Million
-123,757 Reduced 7.31%
1,570,114 $105 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $1.98 Million - $2.23 Million
-33,353 Reduced 1.93%
1,693,871 $107 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $5.59 Million - $6.33 Million
-96,809 Reduced 5.31%
1,727,224 $107 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $9.63 Million - $10.7 Million
-167,700 Reduced 8.42%
1,824,033 $110 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $17.3 Million - $20.3 Million
316,300 Added 18.88%
1,991,733 $117 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $11.4 Million - $16.6 Million
-246,600 Reduced 12.83%
1,675,433 $93.4 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $31.9 Million - $41.6 Million
648,351 Added 50.9%
1,922,033 $123 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $183,911 - $218,053
-4,300 Reduced 0.34%
1,273,682 $64.6 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $2.62 Million - $2.9 Million
58,700 Added 4.81%
1,277,982 $58 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $6.01 Million - $7.17 Million
-133,191 Reduced 9.85%
1,219,282 $58.2 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $2.16 Million - $2.81 Million
44,400 Added 3.39%
1,352,473 $70.3 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $5.29 Million - $5.97 Million
95,880 Added 7.91%
1,308,073 $81.2 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $8.35 Million - $10.4 Million
-165,300 Reduced 12.0%
1,212,193 $0
Q1 2018

May 09, 2018

SELL
$59.92 - $68.98 $781,236 - $899,361
-13,038 Reduced 0.94%
1,377,493 $87.1 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $12.4 Million - $13.5 Million
206,100 Added 17.4%
1,390,531 $85.2 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $65.4 Million - $75.5 Million
1,184,431
1,184,431 $75.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.